Search

Robert Stockton Jones Jr.

Examiner (ID: 3854)

Most Active Art Unit
1762
Art Unit(s)
1796, 1762
Total Applications
1302
Issued Applications
945
Pending Applications
17
Abandoned Applications
352

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6770444 [patent_doc_number] => 20030216384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Composition and method for treating hypertension' [patent_app_type] => new [patent_app_number] => 10/255447 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7387 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216384.pdf [firstpage_image] =>[orig_patent_app_number] => 10255447 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/255447
Composition and method for treating hypertension Sep 24, 2002 Abandoned
Array ( [id] => 7270485 [patent_doc_number] => 20040059003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'NMDA receptor antagonist formulation with reduced neurotoxicity' [patent_app_type] => new [patent_app_number] => 10/256283 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13343 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20040059003.pdf [firstpage_image] =>[orig_patent_app_number] => 10256283 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/256283
NMDA receptor antagonist formulation with reduced neurotoxicity Sep 24, 2002 Issued
Array ( [id] => 6721387 [patent_doc_number] => 20030055077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/239717 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7868 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055077.pdf [firstpage_image] =>[orig_patent_app_number] => 10239717 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/239717
Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists Sep 24, 2002 Abandoned
Array ( [id] => 7265165 [patent_doc_number] => 20040242701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Amines as ant-alcoholism agents' [patent_app_type] => new [patent_app_number] => 10/489251 [patent_app_country] => US [patent_app_date] => 2004-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3401 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242701.pdf [firstpage_image] =>[orig_patent_app_number] => 10489251 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/489251
Amines as anti-alcoholism agents Sep 18, 2002 Issued
Array ( [id] => 6751040 [patent_doc_number] => 20030045561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Method of treating isolated systolic hypertension' [patent_app_type] => new [patent_app_number] => 10/247035 [patent_app_country] => US [patent_app_date] => 2002-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1819 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045561.pdf [firstpage_image] =>[orig_patent_app_number] => 10247035 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/247035
Method of treating isolated systolic hypertension Sep 18, 2002 Abandoned
Array ( [id] => 6814179 [patent_doc_number] => 20030073729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Medicaments for diabetic complication and neuropathy, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/244433 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4928 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073729.pdf [firstpage_image] =>[orig_patent_app_number] => 10244433 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/244433
Medicaments for diabetic complication and neuropathy, and uses thereof Sep 16, 2002 Abandoned
Array ( [id] => 6688930 [patent_doc_number] => 20030032655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Heme oxygenase-1 inducers or induction enhancers' [patent_app_type] => new [patent_app_number] => 10/221798 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2712 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032655.pdf [firstpage_image] =>[orig_patent_app_number] => 10221798 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/221798
Heme oxygenase-1 inducers or induction enhancers Sep 16, 2002 Abandoned
Array ( [id] => 720323 [patent_doc_number] => 07049334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Enhancement of learning and memory and treatment of amnesia' [patent_app_type] => utility [patent_app_number] => 10/242826 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6216 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049334.pdf [firstpage_image] =>[orig_patent_app_number] => 10242826 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/242826
Enhancement of learning and memory and treatment of amnesia Sep 12, 2002 Issued
Array ( [id] => 6818277 [patent_doc_number] => 20030069235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Treatment for ocular infections' [patent_app_type] => new [patent_app_number] => 10/238449 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3278 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069235.pdf [firstpage_image] =>[orig_patent_app_number] => 10238449 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/238449
Treatment for ocular infections Sep 9, 2002 Abandoned
Array ( [id] => 6740868 [patent_doc_number] => 20030158237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Combination of antioxidant substances for the treatment of alzheimer\'s disease' [patent_app_type] => new [patent_app_number] => 10/235613 [patent_app_country] => US [patent_app_date] => 2002-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10275 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158237.pdf [firstpage_image] =>[orig_patent_app_number] => 10235613 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/235613
Combination of antioxidant substances for the treatment of alzheimer's disease Sep 3, 2002 Abandoned
Array ( [id] => 6674820 [patent_doc_number] => 20030060423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Co-therapy for the treatment of dementia and associated behavioral manifestations comprising anticonvulsant derivatives and acetylcholinesterase inhibitors' [patent_app_type] => new [patent_app_number] => 10/229878 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6281 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060423.pdf [firstpage_image] =>[orig_patent_app_number] => 10229878 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/229878
Co-therapy for the treatment of dementia and associated behavioral manifestations comprising anticonvulsant derivatives and acetylcholinesterase inhibitors Aug 27, 2002 Abandoned
Array ( [id] => 6779241 [patent_doc_number] => 20030050323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives' [patent_app_type] => new [patent_app_number] => 10/220216 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10096 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050323.pdf [firstpage_image] =>[orig_patent_app_number] => 10220216 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/220216
Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives Aug 27, 2002 Abandoned
Array ( [id] => 582752 [patent_doc_number] => 07449451 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks' [patent_app_type] => utility [patent_app_number] => 10/229274 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6536 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449451.pdf [firstpage_image] =>[orig_patent_app_number] => 10229274 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/229274
Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks Aug 27, 2002 Issued
Array ( [id] => 6745735 [patent_doc_number] => 20030022918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Farnesyl protein transferase inhibitor combinations with an her2 antibody' [patent_app_type] => new [patent_app_number] => 10/220217 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9927 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022918.pdf [firstpage_image] =>[orig_patent_app_number] => 10220217 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/220217
Farnesyl protein transferase inhibitor combinations with an her2 antibody Aug 27, 2002 Abandoned
Array ( [id] => 6658307 [patent_doc_number] => 20030078281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents' [patent_app_type] => new [patent_app_number] => 10/220220 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10462 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078281.pdf [firstpage_image] =>[orig_patent_app_number] => 10220220 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/220220
Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents Aug 27, 2002 Abandoned
Array ( [id] => 6761964 [patent_doc_number] => 20030125326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Farnesyl protein transferase inhibitor combinations' [patent_app_type] => new [patent_app_number] => 10/220218 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10475 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125326.pdf [firstpage_image] =>[orig_patent_app_number] => 10220218 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/220218
Farnesyl protein transferase inhibitor combinations Aug 27, 2002 Abandoned
Array ( [id] => 6674877 [patent_doc_number] => 20030060480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Farnesyl protein transferase inhibitor combinations with vinca alkaloids' [patent_app_type] => new [patent_app_number] => 10/220398 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10114 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060480.pdf [firstpage_image] =>[orig_patent_app_number] => 10220398 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/220398
Farnesyl protein transferase inhibitor combinations with vinca alkaloids Aug 27, 2002 Abandoned
Array ( [id] => 6745631 [patent_doc_number] => 20030022814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Method for treating or preventing depression' [patent_app_type] => new [patent_app_number] => 10/204876 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11183 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022814.pdf [firstpage_image] =>[orig_patent_app_number] => 10204876 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/204876
Method for treating or preventing depression Aug 22, 2002 Abandoned
Array ( [id] => 6674908 [patent_doc_number] => 20030060511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Method for treatment of ocular hypertension and glaucoma' [patent_app_type] => new [patent_app_number] => 10/224923 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4859 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060511.pdf [firstpage_image] =>[orig_patent_app_number] => 10224923 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/224923
Method for treatment of ocular hypertension and glaucoma Aug 21, 2002 Abandoned
Array ( [id] => 6652950 [patent_doc_number] => 20030008809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Use of 5-HT (3) receptor antagonists for treating musculoeskeletal diseases' [patent_app_type] => new [patent_app_number] => 10/224938 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5070 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008809.pdf [firstpage_image] =>[orig_patent_app_number] => 10224938 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/224938
Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases Aug 20, 2002 Issued
Menu